1,150
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Using Saliva Epigenetic Data to Develop and Validate a Multivariable Predictor of Esophageal Cancer Status

, , , ORCID Icon, , , , , ORCID Icon, & ORCID Icon show all, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , & show all
Pages 109-125 | Received 10 Jul 2023, Accepted 04 Jan 2024, Published online: 16 Jan 2024

References

  • Siegel RL , Miller KD , Fuchs HE , Jemal A . Cancer statistics, 2021. CA Cancer J. Clin. 71(1), 7–33 (2021).
  • Pennathur A , Gibson MK , Jobe BA , Luketich JD . Oesophageal carcinoma. Lancet 381(9864), 400–412 (2013).
  • Huang J , Koulaouzidis A , Marlicz W et al. Global burden, risk factors, and trends of esophageal cancer: an analysis of cancer registries from 48 countries. Cancers 13(1), 141 (2021).
  • Fitzgerald RC , di Pietro M , Ragunath K et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut. 63(1), 7–42 (2014).
  • Haidry R , Lovat L . Long-term durability of radiofrequency ablation for Barrett’s-related neoplasia. Curr. Opin. Gastroenterol. 31(4), 316–320 (2015).
  • Haidry RJ , Dunn JM , Butt MA et al. Radiofrequency ablation and endoscopic mucosal resection for dysplastic Barrett’s esophagus and early esophageal adenocarcinoma: outcomes of the UK National Halo RFA Registry. Gastroenterology 145(1), 87–95 (2013).
  • Haidry RJ , Lipman G , Banks MR et al. Comparing outcome of radiofrequency ablation in Barrett’s with high grade dysplasia and intramucosal carcinoma: a prospective multicenter UK registry. Endoscopy 47(11), 980–987 (2015).
  • Domper Arnal MJ , Ferrández Arenas Á , Lanas Arbeloa Á . Esophageal cancer: risk factors, screening and endoscopic treatment in Western and Eastern countries. World J. Gastroenterol. 21(26), 7933–7943 (2015).
  • Rubenstein JH , Shaheen NJ . Epidemiology, diagnosis, and management of esophageal adenocarcinoma. Gastroenterology 149(2), 302–317.e1 (2015).
  • Lee A , Khulusi S , Watson R . Which interval is most crucial to presentation and survival in gastroesophageal cancer: a systematic review. J. Adv. Nurs. 73(10), 2270–2282 (2017).
  • Mandel ID . Salivary diagnosis: more than a lick and a promise. J. Am. Dent. Assoc. 124(1), 85–87 (1993).
  • Sciascia S , Bentow C , Radin M et al. Detection of Autoantibodies in Saliva as New Avenue for the Diagnosis and Management of Autoimmune Patients. Diagnostics (Basel). 12(8), 2026 (2022).
  • Puneeta Vohra , Vikram Belkhode , Sharayu Nimonkar et al. Evaluation and diagnostic usefulness of saliva for detection of HIV antibodies: A cross-sectional study. J. Family Med. Prim. Care. 9(5), 2437–2441 (2020).
  • Yoshizawa JM , Schafer CA , Schafer JJ , Farrell JJ , Paster BJ , Wong DTW . Salivary biomarkers: toward future clinical and diagnostic utilities. Clin. Microbiol. Rev. 26(4), 781–791 (2013).
  • Nunes AP , Oliveira IO , Santos BR et al. Quality of DNA extracted from saliva samples collected with the Oragene™ DNA self-collection kit. BMC Med. Res. Methodol. 12(1), 65 (2012).
  • Ehrlich M . DNA hypomethylation in cancer cells. Epigenomics 1(2), 239–259 (2009).
  • Kulis M , Esteller M . DNA methylation and cancer. Adv. Genet. 70, 27–56 (2010).
  • Nephew KP , Huang TH-M . Epigenetic gene silencing in cancer initiation and progression. Cancer Lett. 190(2), 125–133 (2003).
  • Tang Q , Cheng J , Cao X , Surowy H , Burwinkel B . Blood-based DNA methylation as biomarker for breast cancer: a systematic review. Clin. Epigenetics 8(1), 115 (2016).
  • Locke WJ , Guanzon D , Ma C et al. DNA methylation cancer biomarkers: translation to the clinic. Front. Genet. 10, 1150 (2019).
  • Rapado-González Ó , Martínez-Reglero C , Salgado-Barreira Á et al. Salivary DNA methylation as an epigenetic biomarker for head and neck cancer. Part I: a diagnostic accuracy meta-analysis. J. Pers. Med. 11(6), 568 (2021).
  • Righini C , de Fraipont F , Timsit J-F et al. Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence. Clin. Cancer Res. 13, 1179–1185 (2007).
  • Peng M , Chen C , Hulbert A , Brock MV , Yu F . Non-blood circulating tumor DNA detection in cancer. Oncotarget 8(40), 69162–69173 (2017).
  • DNA Genotek . Oragene: collection instructions. www.dnagenotek.com/row/support/collection-instructions/oragene-one/ON-500andON-600.html
  • Frommer M , McDonald LE , Millar DS et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl Acad. Sci. USA 89(5), 1827–1831 (1992).
  • Pidsley R , Zotenko E , Peters TJ et al. Critical evaluation of the Illumina MethylationEPIC BeadChip microarray for whole-genome DNA methylation profiling. Genome Biol. 17, 208 (2016).
  • Price EM , Robinson WP . Adjusting for batch effects in DNA methylation microarray data, a lesson learned. Front. Genet. 9, 83 (2018).
  • R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria (2021).
  • Aryee MJ , Jaffe AE , Corrada-Bravo H et al. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics 30(10), 1363–1369 (2014).
  • Bioconductor.org . IlluminaHumanMethylationEPICanno.ilm10b4.hg19. http://bioconductor.org/packages/IlluminaHumanMethylationEPICanno.ilm10b4.hg19/
  • Fortin J-P , Fertig E , Hansen K . shinyMethyl: interactive quality control of Illumina 450k DNA methylation arrays in R. F1000Res. 3, 175 (2014).
  • Fortin J-P , Labbe A , Lemire M et al. Functional normalization of 450k methylation array data improves replication in large cancer studies. Genome Biol. 15(11), 503 (2014).
  • Teschendorff AE , Breeze CE , Zheng SC , Beck S . A comparison of reference-based algorithms for correcting cell-type heterogeneity in epigenome-wide association studies. BMC Bioinformatics 18(1), 105 (2017).
  • Zheng SC , Webster AP , Dong D et al. A novel cell-type deconvolution algorithm reveals substantial contamination by immune cells in saliva, buccal and cervix. Epigenomics 10(7), 925–940 (2018).
  • Horvath S . DNA methylation age of human tissues and cell types. Genome Biol. 14, 3156(2013).
  • Wang M , Huang J , Liu Y , Ma L , Potash JB , Han S . COMBAT: a combined association test for genes using summary statistics. Genetics 207(3), 883–891 (2017).
  • Cheng L , Sun B , Xiong Y et al. WGCNA-based DNA methylation profiling analysis on allopurinol-induced severe cutaneous adverse reactions: a DNA methylation signature for predisposing drug hypersensitivity. J. Pers. Med. 12(4), 525 (2022).
  • Sugden K , Hannon EJ , Arseneault L et al. Patterns of reliability: assessing the reproducibility and integrity of DNA methylation measurement. Patterns (NY) 1(2), 100014 (2020).
  • Resnik DB , Shamoo AE . Reproducibility and research integrity. Account. Res. 24(2), 116–123 (2017).
  • Miller JA , Cai C , Langfelder P et al. Strategies for aggregating gene expression data: The collapseRows R function. BMC Bioinformatics. 12, 322 (2011).
  • Kuhn M . Building predictive models in R using the caret package. J. Stat. Softw. 28, 1–26 (2008).
  • Jiang L , Kong G , Li C et al. Wrapper Framework for Test-Cost-Sensitive Feature Selection. IEEE Transactions on Systems, Man, and Cybernetics: Systems. 51(3), 1747–1756 (2021).
  • Horvath S . DNA methylation age of human tissues and cell types. Genome Biol. 14(10), 3156 (2013).
  • Bernaards CM , Twisk JW , Snel J , Van Mechelen W , Kemper HC . Is calculating pack-years retrospectively a valid method to estimate life-time tobacco smoking? A comparison between prospectively calculated pack-years and retrospectively calculated pack-years. Addiction 96(11), 1653–1661 (2001).
  • Carter A , Bares C , Lin L et al. Sex-specific and generational effects of alcohol and tobacco use on epigenetic age acceleration in the Michigan longitudinal study. Drug Alcohol Depend. Rep. 4, 100077 (2022).
  • Rosenfeld A , Graham DG , Jevons S et al. Development and validation of a risk prediction model to diagnose Barrett’s oesophagus (MARK-BE): a case–control machine learning approach. Lancet Digit. Health 2(1), e37–e48 (2020).
  • Burch JA , Soares-Weiser K , St John DJB et al. Diagnostic accuracy of faecal occult blood tests used in screening for colorectal cancer: a systematic review. J. Med. Screen. 14(3), 132–137 (2007).
  • Overholt BF , Lightdale CJ , Wang KK et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett’s esophagus: international, partially blinded, randomized phase III trial. Gastrointest. Endosc. 62(4), 488–498 (2005).
  • Li D , Zhang L , Liu Y et al. Specific DNA methylation markers in the diagnosis and prognosis of esophageal cancer. Aging 11(23), 11640–11658 (2019).
  • Salta S , Macedo-Silva C , Miranda-Gonçalves V et al. A DNA methylation-based test for esophageal cancer detection. Biomark. Res. 8(1), 68 (2020).
  • Qin Y , Wu CW , Taylor WR et al. Discovery, validation, and application of novel methylated DNA markers for detection of esophageal cancer in plasma. Clin. Cancer Res. 25(24), 7396–7404 (2019).
  • Salem ME , Puccini A , Xiu J et al. Comparative molecular analyses of esophageal squamous cell carcinoma, esophageal adenocarcinoma, and gastric adenocarcinoma. Oncologist 23(11), 1319–1327 (2018).
  • Lim Y , Wan Y , Vagenas D et al. Salivary DNA methylation panel to diagnose HPV-positive and HPV-negative head and neck cancers. BMC Cancer 16(1), 749 (2016).
  • Di Giulio E , Hassan C , Pickhardt PJ et al. Cost–effectiveness of upper gastrointestinal endoscopy according to the appropriateness of the indication. Scand. J. Gastroenterol. 44(4), 491–498 (2009).
  • Kadri SR , Lao-Sirieix P , O’Donovan M et al. Acceptability and accuracy of a non-endoscopic screening test for Barrett’s oesophagus in primary care: cohort study. BMJ 341, c4372 (2010).
  • National Institute for Health and Care Excellence . ‘Overview: Cytosponge for detecting abnormal cells in the oesophagus (2020). www.nice.org.uk/advice/mib240
  • Ho KMA , Banerjee A , Lawler M , Rutter MD , Lovat LB . Predicting endoscopic activity recovery in England after COVID-19: a national analysis. Lancet Gastroenterol. Hepatol. 6(5), 381–390 (2021).
  • Perisetti A , Goyal H , Sharma N . Gastrointestinal endoscopy in the era of COVID-19. Front. Med. 7, 587602 (2020).
  • Rees CJ , East JE , Oppong K et al. Restarting gastrointestinal endoscopy in the deceleration and early recovery phases of COVID-19 pandemic: guidance from the British Society of Gastroenterology. Clin. Med. 20(4), 352–358 (2020).
  • Hamilton JG . Needle phobia: a neglected diagnosis. J. Fam. Pract. 41(2), 169–175 (1995).
  • McLenon J , Rogers MAM . The fear of needles: a systematic review and meta-analysis. J. Adv. Nurs. 75(1), 30–42 (2019).